BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7511085)

  • 21. Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. I. Generation of human thyroid peroxidase-reactive T cells and their T cell receptor repertoire.
    Martin A; Magnusson RP; Kendler DL; Concepcion E; Ben-Nun A; Davies TF
    J Clin Invest; 1993 Apr; 91(4):1567-74. PubMed ID: 7682574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion.
    Chu E; Umetsu D; Yunis E; Geha RS
    Hum Immunol; 1983 Nov; 8(3):217-26. PubMed ID: 6196340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope.
    Quaratino S; Feldmann M; Dayan CM; Acuto O; Londei M
    J Exp Med; 1996 Feb; 183(2):349-58. PubMed ID: 8627148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
    Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
    Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
    Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
    Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease.
    Lundin KE; Sollid LM; Anthonsen D; Norén O; Molberg O; Thorsby E; Sjöström H
    Gastroenterology; 1997 Mar; 112(3):752-9. PubMed ID: 9041236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense.
    Hung SC; Hou T; Jiang W; Wang N; Qiao SW; Chow IT; Liu X; van der Burg SH; Koelle DM; Kwok WW; Sollid LM; Mellins ED
    J Immunol; 2019 May; 202(9):2558-2569. PubMed ID: 30926644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.
    van de Wal Y; Kooy YM; van Veelen PA; Peña SA; Mearin LM; Molberg O; Lundin KE; Sollid LM; Mutis T; Benckhuijsen WE; Drijfhout JW; Koning F
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10050-4. PubMed ID: 9707598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
    Qiao SW; Bergseng E; Molberg O; Jung G; Fleckenstein B; Sollid LM
    J Immunol; 2005 Jul; 175(1):254-61. PubMed ID: 15972656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
    Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
    Scand J Immunol; 1997 Jul; 46(1):103-8. PubMed ID: 9246215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gliadin-Specific CD8
    Picascia S; Sidney J; Camarca A; Mazzarella G; Giardullo N; Greco L; Auricchio R; Auricchio S; Troncone R; Sette A; Gianfrani C
    J Immunol; 2017 Mar; 198(5):1838-1845. PubMed ID: 28148736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
    Arentz-Hansen H; McAdam SN; Molberg Ø; Fleckenstein B; Lundin KE; Jørgensen TJ; Jung G; Roepstorff P; Sollid LM
    Gastroenterology; 2002 Sep; 123(3):803-9. PubMed ID: 12198706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
    Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
    Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen?
    Barbeau WE; Novascone MA; Elgert KD
    Mol Immunol; 1997 May; 34(7):535-41. PubMed ID: 9364219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.